Results 41 to 50 of about 1,122,864 (370)

Raising Expectations For Subunit Vaccine [PDF]

open access: yesThe Journal of Infectious Diseases, 2014
Multidose regimens are recommended for all prophylactic subunit vaccines. Recent findings from clinical trials of an human papillomavirus virus-like particle vaccine suggest that it may be possible to develop effective single-dose subunit vaccines.
John T, Schiller, Douglas R, Lowy
openaire   +2 more sources

Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine

open access: yesFrontiers in Immunology, 2018
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (Mtb), kills 5,000 people per day globally. Rapid development and spread of various multi drug-resistant strains of Mtb emphasize that an effective vaccine is still the most ...
Nancy Gupta   +5 more
doaj   +1 more source

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates

open access: yesNature Communications, 2020
SARS-CoV-2 is the underlying cause for the COVID-19 pandemic. Like most enveloped RNA viruses, SARS-CoV-2 uses a homotrimeric surface antigen to gain entry into host cells.
Joshua G. Liang   +24 more
semanticscholar   +1 more source

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

open access: yesnpj Vaccines, 2022
Adjuvants enhance the magnitude and the durability of the immune response to vaccines. However, there is a paucity of comparative studies on the nature of the immune responses stimulated by leading adjuvant candidates.
Lilit Grigoryan   +29 more
semanticscholar   +1 more source

Viral Subunits for Rabies Vaccination [PDF]

open access: yesNature, 1969
RECENT work with adenovirus1, Sindbis virus2 and the viruses causing influenza3, measles4, vesicular stomatitis5 and German measles6 has shown that subunits of the viruses can stimulate the production of neutralizing antibodies, and in some cases can be used as vaccines.
J, Crick, F, Brown
openaire   +2 more sources

Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence

open access: yesBMC Medicine, 2018
de Boer and colleagues present a cost-effectiveness analysis based in the Netherlands of two vaccines available for the prevention of herpes zoster. Zostavax® was the first vaccine available for the prevention of herpes zoster in older adults.
Chester B. Good   +2 more
doaj   +1 more source

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium [PDF]

open access: yes, 2019
Funding text The authors are grateful for the vital contributions of the participating study volunteers, clinicians, nurses, and laboratory technicians at the Surrey study site.
Bodinham, C.   +16 more
core   +1 more source

Carbohydrate Immune Adjuvants in Subunit Vaccines [PDF]

open access: yesPharmaceutics, 2020
Modern subunit vaccines are composed of antigens and a delivery system and/or adjuvant (immune stimulator) that triggers the desired immune responses. Adjuvants mimic pathogen-associated molecular patterns (PAMPs) that are typically associated with infections.
Sahra Bashiri   +3 more
openaire   +4 more sources

Duality of β-glucan microparticles: antigen carrier and immunostimulants [PDF]

open access: yes, 2016
Designing efficient recombinant mucosal vaccines against enteric diseases is still a major challenge. Mucosal delivery of recombinant vaccines requires encapsulation in potent immunostimulatory particles to induce an efficient immune response. This paper
Baert, Kim   +4 more
core   +2 more sources

Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach

open access: yesVaccines, 2020
Respiratory syncytial virus (RSV) is primarily associated with respiratory disorders globally. Despite the availability of information, there is still no competitive vaccine available for RSV.
Muhammad Tahir ul Qamar   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy